SLPI and Marinesco-Sjogren syndrome: In contrast, in stage III patients with MSS tumors high SLPI expression was associated with a significantly increased disease-free survival (HRR 0.58, P-value 0.04, 95% confidence interval 0.34–0.99, Fig. 2d).